Studies from 2010 reveal many advances in thyroid cancer research
As an overview of medical research on thyroid cancer for 2010, EmpowHer published the top findings in the field. Among several advances in research, one important finding was that thyrotropin suppression therapy may not be necessary.
Researchers found in a randomized controlled trial in October that this therapy does not significantly increase disease-free survival time, according to the news source. They discovered that when the thyroid is completely removed, patients are often given synthetic thyroid hormones at high enough doses to suppress production of TSH, which is also called thyrotropin.
In addition, scientists found that Hashimoto's thyroiditis is associated with thyroid cancer. Researchers suggested observation of patients with Hashimoto's disease for development of the condition.
This year, studies also revealed that ultrasound is effective for diagnosing medullary thyroid carcinoma.
Thyroid cancer is the fastest-growing cancer in the U.S., according to the American Cancer Society, which estimates that 44,670 new cases will be diagnosed nationwide this year. Additionally, the National Cancer Institute reports that there are 19,500 thyroid cancer diagnoses in the U.S. annually, and up to 1,500 will die from it. While the disease appears most often in people over 30, thyroid cancer can occur at any age.